WATSON 240 0.5 (Lorazepam 0.5 mg)
Pill imprint WATSON 240 0.5 has been identified as Lorazepam 0.5 mg.
Lorazepam is used in the treatment of anxiety; insomnia; borderline personality disorder; cervical dystonia; sedation (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- WATSON 240 0.5
- 0.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Benzodiazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
|NDC Code||Manufacturer / Repackager|
|63739-0499||McKesson Packaging Services|
|55045-1372||Dispensing Solutions Inc. (repackager)|
|16590-0143||Stat RX USA LLC (repackager)|
|66336-0363||Dispensing Solutions Inc. (repackager)|
|66267-0133||Nucare Pharmaceuticals Inc (repackager)|
|43063-0057||PDRX Pharmaceuticals Inc (repackager)|
|55289-0402||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about lorazepam
- Lorazepam solution
- Lorazepam injection
- Lorazepam (Advanced Reading)
- Lorazepam Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.